合成生物学市场分析及预测（至2035年）：依类型、产品类型、服务、技术、组件、应用、最终使用者及流程划分

合成生物学市场预计将从2024年的137亿美元成长到2034年的548亿美元，复合年增长率约为15.4%。合成生物学市场涵盖新型生物实体的设计和构建，以及现有生物系统的重新设计。它融合了生物学、工程学和电脑科学等领域，旨在为医疗保健、农业和环境永续性开发解决方案。在DNA合成、基因组编辑技术和生物资讯学进步的推动下，该市场为生物製药、生质燃料和生物降解材料领域带来了变革性的机会。不断增长的投资和监管支持也进一步推动了其发展。

合成生物学市场正经历强劲扩张，这主要得益于基因工程和生物资讯学的进步。在这个充满活力的市场格局中，基因合成细分市场成长最为迅猛，这主要归功于其在建构精确DNA序列方面所扮演的核心角色。合成基因日益广泛地应用于製药、农业和工业生物技术领域。第二大细分市场是基因组编辑，尤其是CRISPR技术，它彻底革新了标靶基因修饰。其应用范围涵盖了从培育抗病作物到创新疗法等许多领域。生物资讯学领域也正蓬勃发展，它为分析复杂的生物数据提供了重要工具，这对于合成生物学的研发至关重要。代谢工程也展现出巨大的潜力，因为它能够优化生质燃料和特用化学品的生产流程。这些细分市场的整合表明，市场正朝着提高效率和创新能力的整合解决方案发展。预计对合成生物学的投资将加速成长，从而在各个工业领域创造新的机会。

合成生物学领域充满活力，市场参与企业众多。新参与企业不断推出创新产品，进一步加剧了市场份额的分散化。随着技术进步和竞争加剧，定价策略也不断演变。频繁的新产品发布是该行业的显着特征，反映了快速创新的发展。各公司致力于开发高性价比的解决方案，以在这个快速成长的市场中扩大市场占有率。对永续和环保产品的关注也影响着定价和产品开发策略。合成生物学领域竞争异常激烈，主要参与者都在努力取得技术优势。基准数据显示，主要企业正大力投资研发，以维持其竞争优势。监管至关重要，北美和欧洲等地区实施了严格的政策。这些法规影响产品开发和打入市场策略。在基因编辑技术和生物资讯学进步的推动下，市场呈现成长迹象。然而，监管合规和伦理考量等挑战依然存在。这些因素将对合成生物学市场的未来发展轨迹产生关键影响。

主要趋势和驱动因素：

合成生物学市场正经历强劲成长，这主要得益于基因工程的进步和生物技术领域投资的不断增加。关键趋势包括新型合成生物体和生物基产品的开发，这些产品正在改变製药、农业和能源等产业。人工智慧 (AI) 和机器学习与合成生物学的日益融合正在加速研发进程，从而实现更精准、更有效率的生物系统设计。另一个关键趋势是对永续和环境友善解决方案日益增长的需求，这推动了合成生物学在可生物降解材料和可再生化学品开发中的应用。此外，学术机构、研究组织和产业界之间日益密切的合作正在促进合成生物学应用的创新和商业化。政府的支持和有利的法规结构进一步加速了市场扩张。此外，人们对个人化医疗的日益关注以及合成生物学在疾病治疗领域革命性潜力也是关键驱动因素。企业正在投资开发基于合成生物学的疗法，这些疗法有望提供目标有效的治疗方法。随着合成生物学不断应对全球挑战并在各个领域开拓新的机会，预计该市场将实现显着成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

• 宏观经济分析
• 市场趋势
• 市场驱动因素
• 市场机会
• 市场限制
• 复合年均成长率：成长分析
• 影响分析
• 新兴市场
• 技术蓝图
• 战略框架

第四章 细分市场分析

• 市场规模及预测：依类型
  • 基因迴路
  • 基础生物
  • DNA合成
  • 基因组工程
• 市场规模及预测：依产品划分
  • 合成DNA
  • 合成基因
  • 合成细胞
  • 异种生物製品
  • 合成RNA
• 市场规模及预测：依服务划分
  • 基因合成服务
  • 基因组编辑服务
  • 生物资讯服务
• 市场规模及预测：依技术划分
  • CRISPR
  • 基因编辑
  • DNA定序
  • 生物资讯学
  • 基因合成
• 市场规模及预测：依组件划分
  • 寡核苷酸
  • 酵素
  • 克隆技术套件
  • 基础生物
• 市场规模及预测：依应用领域划分
  • 医疗应用
  • 工业应用
  • 环境应用
  • 农业应用
• 市场规模及预测：依最终用户划分
  • 生技公司
  • 製药公司
  • 学术研究机构
• 市场规模及预测：依製程划分
  • 路线工程
  • 代谢工程
  • 无细胞系统

第五章 区域分析

• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 其他拉丁美洲地区
• 亚太地区
  • 中国
  • 印度
  • 韩国
  • 日本
  • 澳洲
  • 台湾
  • 亚太其他地区
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 义大利
  • 其他欧洲地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非
  • 撒哈拉以南非洲
  • 其他中东和非洲地区

第六章 市场策略

• 需求与供给差距分析
• 贸易和物流限制
• 价格、成本和利润率趋势
• 市场渗透率
• 消费者分析
• 法规概述

第七章 竞争讯息

• 市场定位
• 市场占有率
• 竞争基准
• 主要企业的策略

第八章 公司简介

• Ginkgo Bioworks
• Zymergen
• Amyris
• Twist Bioscience
• Synlogic
• Codexis
• Intrexon
• Genomatica
• Arzeda
• Modern Meadow
• Evolva
• Biosyntia
• Green Biologics
• Conagen
• Antheia
• Benson Hill Biosystems
• Agilent Technologies
• Arbor Biosciences
• Pivot Bio
• Checkerspot

第九章：关于我们

Synthetic Biology Market is anticipated to expand from $13.7 billion in 2024 to $54.8 billion by 2034, growing at a CAGR of approximately 15.4%. The Synthetic Biology Market encompasses the design and construction of new biological entities or the redesign of existing biological systems. It integrates disciplines such as biology, engineering, and computer science to develop solutions for healthcare, agriculture, and environmental sustainability. This market is driven by advancements in DNA synthesis, genome editing technologies, and bioinformatics, offering transformative opportunities in biopharmaceuticals, biofuels, and biodegradable materials. Increasing investments and regulatory support are further propelling its growth.

The Synthetic Biology Market is experiencing robust expansion, propelled by advancements in genetic engineering and bioinformatics. Within this dynamic landscape, the gene synthesis sub-segment is the top performer, driven by its pivotal role in enabling precise DNA sequence creation. Synthetic genes are increasingly utilized across pharmaceuticals, agriculture, and industrial biotechnology. The second highest performing sub-segment is genome editing, particularly CRISPR technology, which has revolutionized targeted genetic modifications. Its applications span from developing disease-resistant crops to innovative therapeutic solutions. The bioinformatics segment is gaining momentum, as it provides critical tools for analyzing complex biological data. This is essential for synthetic biology research and development. Metabolic engineering also shows promise, with its capacity to optimize microbial production processes for biofuels and specialty chemicals. The convergence of these sub-segments indicates a trend towards integrated solutions that enhance efficiency and innovation. Investment in synthetic biology is poised to accelerate, unlocking new opportunities across diverse industries.

Synthetic biology is witnessing a dynamic landscape with a diverse array of market participants. The market share is increasingly fragmented as new entrants introduce innovative products. Pricing strategies are evolving, driven by technological advancements and increased competition. The industry is marked by frequent new product launches, reflecting the rapid pace of innovation. Companies are focusing on developing cost-effective solutions to capture a larger share of this burgeoning market. The emphasis on sustainable and eco-friendly products is also shaping pricing and product development strategies. The competitive landscape in synthetic biology is intense, with key players striving for technological superiority. Benchmarking reveals that leading firms are investing heavily in research and development. This is to maintain their competitive edge. Regulatory influences are significant, with stringent policies in regions like North America and Europe. These regulations impact product development and market entry strategies. The market is poised for growth, driven by advancements in gene editing and bioinformatics. However, challenges such as regulatory compliance and ethical considerations persist. These factors are pivotal in shaping the future trajectory of the synthetic biology market.

Geographical Overview:

The synthetic biology market is experiencing notable growth across diverse regions, each showcasing unique opportunities. North America leads the charge, propelled by substantial investments in research and development, alongside a robust biotechnology sector. The region's regulatory framework supports innovation, fostering a conducive environment for market expansion. Europe follows closely, with strong governmental support and funding initiatives aimed at advancing synthetic biology research. The region's commitment to sustainability and bio-based solutions enhances its market potential. In Asia Pacific, the market is rapidly growing, driven by increasing investments in biotechnology and synthetic biology startups. Countries like China and India are emerging as key players, with significant advancements in genome editing and bioengineering. Latin America and the Middle East & Africa are nascent markets with promising potential. Brazil and South Africa are witnessing rising investments in synthetic biology, recognizing its potential to transform agriculture, healthcare, and industrial processes.

The synthetic biology market is navigating a complex landscape shaped by global tariffs, geopolitical tensions, and evolving supply chain trends. In Japan and South Korea, strategic investments in biotechnology and synthetic biology are increasing as they seek to mitigate risks from trade tensions and secure technological independence. China, under pressure from export restrictions, is accelerating its domestic capabilities in synthetic biology, focusing on innovation and self-sufficiency. Taiwan, a pivotal player in semiconductor manufacturing, is diversifying its capabilities to include synthetic biology, though geopolitical risks remain a concern. Globally, the synthetic biology market is poised for robust growth, with projections indicating significant expansion by 2035. Meanwhile, Middle East conflicts contribute to supply chain volatility and energy price fluctuations, indirectly impacting production costs and market dynamics.

Key Trends and Drivers:

The synthetic biology market is experiencing robust growth, driven by advancements in genetic engineering and increased investment in biotechnology. Key trends include the development of novel synthetic organisms and bio-based products, which are transforming industries such as pharmaceuticals, agriculture, and energy. The convergence of artificial intelligence and machine learning with synthetic biology is accelerating research and development, enabling more precise and efficient design of biological systems. Another significant trend is the rising demand for sustainable and eco-friendly solutions, which is propelling the adoption of synthetic biology in creating biodegradable materials and renewable chemicals. The market is also witnessing an increase in collaborative efforts between academic institutions, research organizations, and industry players, fostering innovation and commercialization of synthetic biology applications. Government support and favorable regulatory frameworks are further catalyzing market expansion. Moreover, the growing focus on personalized medicine and the potential of synthetic biology to revolutionize disease treatment is a major driver. Companies are investing in the development of synthetic biology-based therapeutics, which promise to offer targeted and effective treatment options. The synthetic biology market is poised for significant growth as it continues to address global challenges and unlock new opportunities across various sectors.

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Component
• 2.6 Key Market Highlights by Application
• 2.7 Key Market Highlights by End User
• 2.8 Key Market Highlights by Process

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Gene Circuits
  • 4.1.2 Chassis Organisms
  • 4.1.3 DNA Synthesis
  • 4.1.4 Genome Engineering
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Synthetic DNA
  • 4.2.2 Synthetic Genes
  • 4.2.3 Synthetic Cells
  • 4.2.4 Xenobiology Products
  • 4.2.5 Synthetic RNA
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Gene Synthesis Services
  • 4.3.2 Genome Editing Services
  • 4.3.3 Bioinformatics Services
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 CRISPR
  • 4.4.2 Gene Editing
  • 4.4.3 DNA Sequencing
  • 4.4.4 Bioinformatics
  • 4.4.5 Gene Synthesis
• 4.5 Market Size & Forecast by Component (2020-2035)
  • 4.5.1 Oligonucleotides
  • 4.5.2 Enzymes
  • 4.5.3 Cloning Technology Kits
  • 4.5.4 Chassis Organisms
• 4.6 Market Size & Forecast by Application (2020-2035)
  • 4.6.1 Medical Applications
  • 4.6.2 Industrial Applications
  • 4.6.3 Environmental Applications
  • 4.6.4 Agricultural Applications
• 4.7 Market Size & Forecast by End User (2020-2035)
  • 4.7.1 Biotechnology Companies
  • 4.7.2 Pharmaceutical Companies
  • 4.7.3 Academic and Research Institutes
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Pathway Engineering
  • 4.8.2 Metabolic Engineering
  • 4.8.3 Cell-free Systems

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Component
    • 5.2.1.6 Application
    • 5.2.1.7 End User
    • 5.2.1.8 Process
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Component
    • 5.2.2.6 Application
    • 5.2.2.7 End User
    • 5.2.2.8 Process
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Component
    • 5.2.3.6 Application
    • 5.2.3.7 End User
    • 5.2.3.8 Process
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Component
    • 5.3.1.6 Application
    • 5.3.1.7 End User
    • 5.3.1.8 Process
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Component
    • 5.3.2.6 Application
    • 5.3.2.7 End User
    • 5.3.2.8 Process
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Component
    • 5.3.3.6 Application
    • 5.3.3.7 End User
    • 5.3.3.8 Process
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Component
    • 5.4.1.6 Application
    • 5.4.1.7 End User
    • 5.4.1.8 Process
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Component
    • 5.4.2.6 Application
    • 5.4.2.7 End User
    • 5.4.2.8 Process
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Component
    • 5.4.3.6 Application
    • 5.4.3.7 End User
    • 5.4.3.8 Process
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Component
    • 5.4.4.6 Application
    • 5.4.4.7 End User
    • 5.4.4.8 Process
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Component
    • 5.4.5.6 Application
    • 5.4.5.7 End User
    • 5.4.5.8 Process
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Component
    • 5.4.6.6 Application
    • 5.4.6.7 End User
    • 5.4.6.8 Process
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Component
    • 5.4.7.6 Application
    • 5.4.7.7 End User
    • 5.4.7.8 Process
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Component
    • 5.5.1.6 Application
    • 5.5.1.7 End User
    • 5.5.1.8 Process
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Component
    • 5.5.2.6 Application
    • 5.5.2.7 End User
    • 5.5.2.8 Process
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Component
    • 5.5.3.6 Application
    • 5.5.3.7 End User
    • 5.5.3.8 Process
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Component
    • 5.5.4.6 Application
    • 5.5.4.7 End User
    • 5.5.4.8 Process
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Component
    • 5.5.5.6 Application
    • 5.5.5.7 End User
    • 5.5.5.8 Process
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Component
    • 5.5.6.6 Application
    • 5.5.6.7 End User
    • 5.5.6.8 Process
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Component
    • 5.6.1.6 Application
    • 5.6.1.7 End User
    • 5.6.1.8 Process
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Component
    • 5.6.2.6 Application
    • 5.6.2.7 End User
    • 5.6.2.8 Process
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Component
    • 5.6.3.6 Application
    • 5.6.3.7 End User
    • 5.6.3.8 Process
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Component
    • 5.6.4.6 Application
    • 5.6.4.7 End User
    • 5.6.4.8 Process
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Component
    • 5.6.5.6 Application
    • 5.6.5.7 End User
    • 5.6.5.8 Process

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Ginkgo Bioworks
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Zymergen
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Amyris
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Twist Bioscience
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Synlogic
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Codexis
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Intrexon
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Genomatica
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Arzeda
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Modern Meadow
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Evolva
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Biosyntia
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Green Biologics
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Conagen
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Antheia
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Benson Hill Biosystems
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Agilent Technologies
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Arbor Biosciences
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 Pivot Bio
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Checkerspot
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us